The facility is getting ready to export Made in India vaccines to regulated markets like Europe and the US and will produce half-a-billion doses annually
Serum Institute of India (SII) has opened the world’s largest vaccine manufacturing facility with an investment of Rs 3,000 crore in a capacity expansion move aimed at capturing 10-15 per cent share of the international market.
The institute is getting ready to export Made in India vaccines to regulated markets like Europe and the US from